カテゴリー： QYResearch, 世界, 医療/バイオ

C1エステラーゼ阻害剤（皮下）のグローバル市場2023年：500U、1000U

◆英語タイトル：Global C1 Esterase Inhibitor Subcutaneous Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8704）◆商品コード：QYR23MA8704
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のC1エステラーゼ阻害剤（皮下）市場について調査・分析し、世界のC1エステラーゼ阻害剤（皮下）市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（500U、1000U）、用途別セグメント分析（子供、大人）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Takeda、CSL Behringなどが含まれています。世界のC1エステラーゼ阻害剤（皮下）市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、C1エステラーゼ阻害剤（皮下）市場規模を推定する際に考慮しました。

・C1エステラーゼ阻害剤（皮下）市場の概要
- 製品の定義
- C1エステラーゼ阻害剤（皮下）のタイプ別セグメント
- 世界のC1エステラーゼ阻害剤（皮下）市場規模：タイプ別分析（500U、1000U）
- C1エステラーゼ阻害剤（皮下）の用途別セグメント
- 世界のC1エステラーゼ阻害剤（皮下）市場規模：用途別分析（子供、大人）
- 世界のC1エステラーゼ阻害剤（皮下）市場規模予測（2018年-2029年）
- C1エステラーゼ阻害剤（皮下）の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- C1エステラーゼ阻害剤（皮下）市場の競争状況およびトレンド

・C1エステラーゼ阻害剤（皮下）の地域別市場規模
- 北米のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- アメリカのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- ヨーロッパのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- アジア太平洋のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 中国のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 日本のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 韓国のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- インドのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- オーストラリアのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 中南米のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 中東・アフリカのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）

・タイプ別セグメント：500U、1000U
- 世界のC1エステラーゼ阻害剤（皮下）のタイプ別販売量（2018年-2023年）
- 世界のC1エステラーゼ阻害剤（皮下）のタイプ別売上（2018年-2023年）
- 世界のC1エステラーゼ阻害剤（皮下）のタイプ別価格

・用途別セグメント：子供、大人
- 世界のC1エステラーゼ阻害剤（皮下）の用途別販売量（2018年-2023年）
- 世界のC1エステラーゼ阻害剤（皮下）の用途別売上（2018年-2023年）
- 世界のC1エステラーゼ阻害剤（皮下）の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Takeda、CSL Behring

・産業チェーンと販売チャネルの分析
- C1エステラーゼ阻害剤（皮下）産業チェーン分析
- C1エステラーゼ阻害剤（皮下）の主要原材料
- C1エステラーゼ阻害剤（皮下）の販売チャネル
- C1エステラーゼ阻害剤（皮下）のディストリビューター
- C1エステラーゼ阻害剤（皮下）の主要顧客

・C1エステラーゼ阻害剤（皮下）市場ダイナミクス
- C1エステラーゼ阻害剤（皮下）の業界動向
- C1エステラーゼ阻害剤（皮下）市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

 C1 esterase inhibitor is used to treat or prevent hereditary angioedema (HAE). 
Highlights
The global C1 Esterase Inhibitor Subcutaneous market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for C1 Esterase Inhibitor Subcutaneous is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for C1 Esterase Inhibitor Subcutaneous is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of C1 Esterase Inhibitor Subcutaneous include Takeda and CSL Behring etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for C1 Esterase Inhibitor Subcutaneous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C1 Esterase Inhibitor Subcutaneous.
The C1 Esterase Inhibitor Subcutaneous market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global C1 Esterase Inhibitor Subcutaneous market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C1 Esterase Inhibitor Subcutaneous manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Takeda
CSL Behring
Segment by Type
500U
1000U
Segment by Application
Children
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of C1 Esterase Inhibitor Subcutaneous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of C1 Esterase Inhibitor Subcutaneous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 C1 Esterase Inhibitor Subcutaneous Market Overview
1.1 Product Overview and Scope of C1 Esterase Inhibitor Subcutaneous
1.2 C1 Esterase Inhibitor Subcutaneous Segment by Type
1.2.1 Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Type (2023-2029)
1.2.2 500U
1.2.3 1000U
1.3 C1 Esterase Inhibitor Subcutaneous Segment by Application
1.3.1 Global C1 Esterase Inhibitor Subcutaneous Market Value by Application: (2023-2029)
1.3.2 Children
1.3.3 Adult
1.4 Global C1 Esterase Inhibitor Subcutaneous Market Size Estimates and Forecasts
1.4.1 Global C1 Esterase Inhibitor Subcutaneous Revenue 2018-2029
1.4.2 Global C1 Esterase Inhibitor Subcutaneous Sales 2018-2029
1.4.3 Global C1 Esterase Inhibitor Subcutaneous Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 C1 Esterase Inhibitor Subcutaneous Market Competition by Manufacturers
2.1 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Manufacturers (2018-2023)
2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Manufacturers (2018-2023)
2.3 Global C1 Esterase Inhibitor Subcutaneous Average Price by Manufacturers (2018-2023)
2.4 Global C1 Esterase Inhibitor Subcutaneous Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Product Type & Application
2.7 C1 Esterase Inhibitor Subcutaneous Market Competitive Situation and Trends
2.7.1 C1 Esterase Inhibitor Subcutaneous Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest C1 Esterase Inhibitor Subcutaneous Players Market Share by Revenue
2.7.3 Global C1 Esterase Inhibitor Subcutaneous Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 C1 Esterase Inhibitor Subcutaneous Retrospective Market Scenario by Region
3.1 Global C1 Esterase Inhibitor Subcutaneous Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global C1 Esterase Inhibitor Subcutaneous Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2018-2029
3.2.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2018-2023
3.2.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2024-2029
3.3 Global C1 Esterase Inhibitor Subcutaneous Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2018-2029
3.3.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2018-2023
3.3.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2024-2029
3.4 North America C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.4.1 North America C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.4.3 North America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.5.1 Europe C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.5.3 Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.6.1 Asia Pacific C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.6.3 Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.7.1 Latin America C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.7.3 Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.8.1 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.8.3 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2018-2029)
4.1.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2018-2023)
4.1.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2024-2029)
4.1.3 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Type (2018-2029)
4.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2018-2029)
4.2.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2018-2023)
4.2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2024-2029)
4.2.3 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Type (2018-2029)
4.3 Global C1 Esterase Inhibitor Subcutaneous Price by Type (2018-2029)
5 Segment by Application
5.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2018-2029)
5.1.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2018-2023)
5.1.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2024-2029)
5.1.3 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Application (2018-2029)
5.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2018-2029)
5.2.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2018-2023)
5.2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2024-2029)
5.2.3 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Application (2018-2029)
5.3 Global C1 Esterase Inhibitor Subcutaneous Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda C1 Esterase Inhibitor Subcutaneous Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda C1 Esterase Inhibitor Subcutaneous Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Corporation Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring C1 Esterase Inhibitor Subcutaneous Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Behring C1 Esterase Inhibitor Subcutaneous Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 C1 Esterase Inhibitor Subcutaneous Industry Chain Analysis
7.2 C1 Esterase Inhibitor Subcutaneous Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 C1 Esterase Inhibitor Subcutaneous Production Mode & Process
7.4 C1 Esterase Inhibitor Subcutaneous Sales and Marketing
7.4.1 C1 Esterase Inhibitor Subcutaneous Sales Channels
7.4.2 C1 Esterase Inhibitor Subcutaneous Distributors
7.5 C1 Esterase Inhibitor Subcutaneous Customers
8 C1 Esterase Inhibitor Subcutaneous Market Dynamics
8.1 C1 Esterase Inhibitor Subcutaneous Industry Trends
8.2 C1 Esterase Inhibitor Subcutaneous Market Drivers
8.3 C1 Esterase Inhibitor Subcutaneous Market Challenges
8.4 C1 Esterase Inhibitor Subcutaneous Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ C1エステラーゼ阻害剤（皮下）のグローバル市場2023年：500U、1000U(Global C1 Esterase Inhibitor Subcutaneous Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • JAK1阻害剤のグローバル市場展望 2023年-2029年：口腔、クリーム
  • 薬剤溶出バルーン（DEB）のグローバル市場2023年：末梢DEB、冠動脈DEB
  • 世界のホスホイノシチド3-キナーゼ阻害剤市場インサイト及び予測（Pan-PI3K阻害剤、デュアルPI3K/mTOR阻害剤、その他）
  • 世界の皮下埋め込み型除細動器市場インサイト及び予測（心室性頻拍、肥大型心筋症、心室異形成、その他）
  • 世界のプレハブデータセンターモジュール市場インサイト及び予測（500U以下、501〜1000U、1001〜2000U、2000U以上）